Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/16/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. William H. Ludlam

Wrong Dr. William H. Ludlam?

Vice President , Medical Affairs

Phone: (617) ***-****  HQ Phone
Email: w***@***.com
Local Address:  Newton , Massachusetts , United States
Chiasma Inc.
831 Beacon Street
Newton Centre , Massachusetts 02459
United States

Company Description: Chiasma is a biopharma company focused on creating new drug products by marrying its proprietary technology to approved drugs. This enables drugs to be switched...   more
Background

Employment History

Education

  • M.D.
88 Total References
Web References
William H. Ludlam , M.D., ...
ir.chiasmapharma.com [cached]
William H. Ludlam , M.D., Ph.D., as Vice President of Medical Affairs.
...
Dr. Ludlam came to Chiasma from Novartis Pharmaceuticals Corporation , where he served most recently as Senior Medical Director for
Chiasma Appoints William ...
ir.chiasmapharma.com [cached]
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
...
William H. Ludlam
...
Dr. Ludlam, a highly-regarded academic leader in the pituitary and rare disease space, comes to Chiasma after spending the last four years at Novartis Pharmaceuticals , where he served most recently as Senior Medical Director for the U.S. Clinical Development and Medical Affairs (USCDMA), Pituitary Disorders, Rare Diseases Franchise. Novartis is currently a leading seller of injectable octreotide, one of the standard treatment options for patients suffering from acromegaly.
In his role at Chiasma, Dr. Ludlam will be responsible for developing strategy around clinical and technical information to support the planned commercial launch of Mycapssa™ for the maintenance treatment of adults with acromegaly. He will also lead all medical review activities around the Company's product education campaign, including its presence at key scientific events. In
...
"Dr. Ludlam's extensive academic and industry experience in the rare disease space, particularly pituitary disorders, makes him an ideal choice to help lead the medical strategy for our anticipated launch of Mycapssa™ in 2016," said
...
"Dr. Ludlam has worked firsthand with acromegaly patients, both in his current role at
...
in 2012, Dr. Ludlam spent 15 years in a number of academic and clinical roles. From 2007 to 2011, he served as medical director at the Seattle Pituitary Center within the Neuroscience Institute at the Swedish Medical Center , and from 2002 to 2006 as medical director of the Pituitary Unit at the Oregon Health and Science University . Dr. Ludlam helped develop both treatment centers and conducted clinical research for novel treatment options for pituitary disorders while actively treating patients with acromegaly and Cushing's disease, among other conditions.
Dr. Ludlam holds an M.D. and Ph.D. from the
...
"I am extremely pleased to be joining Chiasma prior to the potential launch of Mycapssa™," said Dr. Ludlam.
Chiasma Appoints William ...
ir.chiasmapharma.com [cached]
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
- Well-known pituitary expert to provide senior medical and technical leadership for Company's planned commercial launch of octreotide capsules (Mycapssa™) - NEWTON, Mass. and JERUSALEM, Israel, Aug. 24, 2015 /PRNewswire/ -- Chiasma, Inc. (NASDAQ: CHMA), a U.S. late-stage biopharmaceutical company developing Mycapssa™ (octreotide capsules) for the maintenance therapy of adult patients with acromegaly, today announced the appointment of William H. Ludlam, M.D., Ph.D., as vice president of me...
About Us | Hormone Health Network
new.hormone.org [cached]
William Ludlam, MD, PhD Novartis Pharmaceuticals
New additions to the team include ...
www.biospace.com [cached]
New additions to the team include Anand Varadan as Chief Commercial Officer and William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs.
...
Dr. Ludlam came to Chiasma from Novartis Pharmaceuticals Corporation, where he served most recently as Senior Medical Director for U.S. Clinical Development and Medical Affairs, Pituitary Disorders, Rare Diseases Franchise.
Other People with the name "Ludlam":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304